SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000947871-23-000181
Filing Date
2023-02-14
Accepted
2023-02-14 16:45:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss1758602_sc13ga.htm SC 13G/A 41869
  Complete submission text file 0000947871-23-000181.txt   43398
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91001 | Film No.: 23630754
SIC: 2834 Pharmaceutical Preparations